• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阳离子-π 和 π-π 堆积相互作用允许通过修饰的奎宁和辛可宁生物碱选择性抑制丁酰胆碱酯酶。

Cation-π and π-π stacking interactions allow selective inhibition of butyrylcholinesterase by modified quinine and cinchonidine alkaloids.

机构信息

Department of Bioorganic Chemistry, Leibniz Institute of Plant Biochemistry, Weinberg 3, D-06120, Halle (Saale), Germany.

出版信息

Biochem Biophys Res Commun. 2011 Jan 28;404(4):935-40. doi: 10.1016/j.bbrc.2010.12.084. Epub 2010 Dec 23.

DOI:10.1016/j.bbrc.2010.12.084
PMID:21185266
Abstract

Scaffold varied quaternized quinine and cinchonidine alkaloid derivatives were evaluated for their selective butyrylcholinesterase (BChE) inhibitory potential. K(i) values were between 0.4-260.5μM (non-competitive inhibition) while corresponding K(i)values to acetylcholinesterase (AChE) ranged from 7.0-400μM exhibiting a 250-fold selectivity for BChE. Docking arrangements (GOLD, PLANT) revealed that the extended aromatic moieties and the quaternized nitrogen of the inhibitors were responsible for specific π-π stacking and π-cation interactions with the choline binding site and the peripheral anionic site of BChE's active site.

摘要

支架不同季铵化奎宁和辛可宁生物碱衍生物被评估为其选择性丁酰胆碱酯酶 (BChE) 抑制潜力。Ki 值在 0.4-260.5μM 之间(非竞争性抑制),而相应的 Ki 值乙酰胆碱酯酶 (AChE) 范围从 7.0-400μM,对 BChE 的选择性为 250 倍。对接安排(GOLD、PLANT)表明,抑制剂的扩展芳基部分和季铵化氮负责与 BChE 活性位点的胆碱结合位点和外周阴离子位点的特定 π-π 堆积和 π-阳离子相互作用。

相似文献

1
Cation-π and π-π stacking interactions allow selective inhibition of butyrylcholinesterase by modified quinine and cinchonidine alkaloids.阳离子-π 和 π-π 堆积相互作用允许通过修饰的奎宁和辛可宁生物碱选择性抑制丁酰胆碱酯酶。
Biochem Biophys Res Commun. 2011 Jan 28;404(4):935-40. doi: 10.1016/j.bbrc.2010.12.084. Epub 2010 Dec 23.
2
Chemical modifications of cinchona alkaloids lead to enhanced inhibition of human butyrylcholinesterase.金鸡纳生物碱的化学修饰导致对人丁酰胆碱酯酶的抑制作用增强。
Nat Prod Commun. 2014 Apr;9(4):455-8.
3
Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.对称双吡啶型胆碱酯酶抑制剂的制备及体外筛选-对重症肌无力影响的初步研究。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1763-6. doi: 10.1016/j.bmcl.2010.01.034. Epub 2010 Jan 20.
4
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.基于金鸡纳生物碱骨架的选择性丁酰胆碱酯酶抑制剂的设计与评价。
PLoS One. 2018 Oct 5;13(10):e0205193. doi: 10.1371/journal.pone.0205193. eCollection 2018.
5
Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.用于阿尔茨海默病治疗的具有双重抑制乙酰胆碱酯酶和β淀粉样蛋白1-42聚集活性的新型哌啶衍生物的合成、体外测定及分子模拟
Bioorg Med Chem. 2007 Oct 15;15(20):6596-607. doi: 10.1016/j.bmc.2007.07.003. Epub 2007 Jul 25.
6
Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors.设计、合成并评价香豆素衍生物与类似依酚氯铵片段的连接物作为高活性和选择性的双结合位点乙酰胆碱酯酶抑制剂。
ChemMedChem. 2010 Sep 3;5(9):1616-30. doi: 10.1002/cmdc.201000210.
7
Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.异靛红衍生物作为乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂的设计、合成与评价
Bioorg Med Chem Lett. 2008 Jul 1;18(13):3790-3. doi: 10.1016/j.bmcl.2008.05.039. Epub 2008 May 16.
8
Kinetics and structure-activity relationship studies on pregnane-type steroidal alkaloids that inhibit cholinesterases.抑制胆碱酯酶的孕甾烷型甾体生物碱的动力学及构效关系研究
Bioorg Med Chem. 2004 May 1;12(9):1995-2003. doi: 10.1016/j.bmc.2004.03.002.
9
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.黄酮类化合物作为人丁酰胆碱酯酶抑制剂的结构特征。
Eur J Med Chem. 2010 Jan;45(1):186-92. doi: 10.1016/j.ejmech.2009.09.041. Epub 2009 Oct 6.
10
Study on dual-site inhibitors of acetylcholinesterase: Highly potent derivatives of bis- and bifunctional huperzine B.乙酰胆碱酯酶双位点抑制剂的研究:双功能和双官能石杉碱乙的高效衍生物
Bioorg Med Chem. 2007 Feb 1;15(3):1394-408. doi: 10.1016/j.bmc.2006.11.009. Epub 2006 Nov 9.

引用本文的文献

1
Targeting Aminoglycoside Acetyltransferase Activity of Mycobacterium tuberculosis (H37Rv) Derived Eis (Enhanced Intracellular Survival) Protein with Quercetin.利用槲皮素靶向结核分枝杆菌(H37Rv)衍生的 Eis(增强细胞内存活)蛋白的氨基糖苷乙酰转移酶活性。
Protein J. 2024 Feb;43(1):12-23. doi: 10.1007/s10930-023-10165-x. Epub 2023 Nov 6.
2
4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease.基于4-氨基喹啉的金刚烷类化合物作为阿尔茨海默病症状性治疗中潜在的抗胆碱酯酶药物
Pharmaceutics. 2022 Jun 20;14(6):1305. doi: 10.3390/pharmaceutics14061305.
3
Validation of the Antioxidant and Enzyme Inhibitory Potential of Selected Triterpenes Using In Vitro and In Silico Studies, and the Evaluation of Their ADMET Properties.
使用体外和计算研究验证选定三萜类化合物的抗氧化和酶抑制潜力,并评估它们的 ADMET 性质。
Molecules. 2021 Oct 20;26(21):6331. doi: 10.3390/molecules26216331.
4
Sulfonylurea Class of Antidiabetic Drugs Inhibit Acetylcholinesterase Activity: Unexplored Auxiliary Pharmacological Benefit toward Alzheimer's Disease.磺脲类抗糖尿病药物抑制乙酰胆碱酯酶活性:对阿尔茨海默病未被探索的辅助药理益处。
ACS Pharmacol Transl Sci. 2021 Jan 6;4(1):193-205. doi: 10.1021/acsptsci.0c00168. eCollection 2021 Feb 12.
5
Therapeutic potency of substituted chromones as Alzheimer's drug: Elucidation of acetylcholinesterase inhibitory activity through spectroscopic and molecular modelling investigation.取代色酮作为阿尔茨海默病药物的治疗效力:通过光谱和分子建模研究阐明乙酰胆碱酯酶抑制活性
Bioimpacts. 2019;9(2):79-88. doi: 10.15171/bi.2019.11. Epub 2019 Mar 8.
6
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.基于金鸡纳生物碱骨架的选择性丁酰胆碱酯酶抑制剂的设计与评价。
PLoS One. 2018 Oct 5;13(10):e0205193. doi: 10.1371/journal.pone.0205193. eCollection 2018.
7
Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.新型阿尔茨海默病乙酰胆碱酯酶抑制剂的合成与生物评价。
Molecules. 2018 Aug 14;23(8):2033. doi: 10.3390/molecules23082033.
8
New Cinchona Oximes Evaluated as Reactivators of Acetylcholinesterase and Butyrylcholinesterase Inhibited by Organophosphorus Compounds.新型金鸡纳肟作为有机磷化合物抑制的乙酰胆碱酯酶和丁酰胆碱酯酶的重活化剂的评估
Molecules. 2017 Jul 22;22(7):1234. doi: 10.3390/molecules22071234.
9
Anti-cholinesterase activity of the standardized extract of Syzygium aromaticum L.丁香标准提取物的抗胆碱酯酶活性
Pharmacogn Mag. 2014 Apr;10(Suppl 2):S276-82. doi: 10.4103/0973-1296.133275.